Clearmind Medicine Says DSMB Unanimously Approved Advancing Phase 1/2 Trial Of CMND-100 To Parts B And C In Alcohol Use Disorder Patients And Healthy Participants

Benzinga Newsdesk www.benzinga.com Positive 93.2%

Neg 0% Neu 0% Pos 93.2%

Comments

No comments yet. Be the first!